Science Translational Medicine
Journal info (provided by editor)
- Issues per year
- 51
- Articles published last year
- 330
- Manuscripts received last year
- 5025
- % accepted last year
- 6
- % immediately rejected last year
- 88
- Open access status
- no
- Manuscript handling fee?
- no
- Kind of complaint procedure
- Editor
- Two-year impact factor
- 17.96
- Five-year impact factor
- 21.12
Aims and Scope
Science Translational Medicine publishes original, peer-reviewed, science-based research articles that promote human health by providing a forum for communication and cross-fertilization among basic, translational, and clinical research practitioners. Content covers all relevant established and emerging disciplines: cardiovascular disease, immunology/vaccines, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, cancer, infectious diseases, policy, behavior, bioengineering, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, and other interdisciplinary approaches.
SciRev ratings (provided by authors) (based on 13 reviews)
Duration of manuscript handling phases | ||
---|---|---|
Duration first review round | 2.0 mnths | compare → |
Total handling time accepted manuscripts | 6.4 mnths | compare → |
Decision time immediate rejection | 4 days | compare → |
Characteristics of peer review process | ||
Average number of review reports | 2.8 | compare → |
Average number of review rounds | 2.8 | compare → |
Quality of review reports | 3.2 | compare → |
Difficulty of reviewer comments | 3.8 | compare → |
Overall rating manuscript handling | 3.2 (range 0-5) | compare → |